A detailed history of Yousif Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Yousif Capital Management, LLC holds 238,684 shares of BMY stock, worth $13.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
238,684
Previous 241,424 1.13%
Holding current value
$13.8 Million
Previous $10 Million 23.19%
% of portfolio
0.14%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$39.66 - $51.75 $108,668 - $141,795
-2,740 Reduced 1.13%
238,684 $12.4 Million
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $926,917 - $1.22 Million
-23,029 Reduced 8.71%
241,424 $10 Million
Q1 2024

Apr 26, 2024

BUY
$47.98 - $54.4 $160,589 - $182,076
3,347 Added 1.28%
264,453 $14.3 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $961,067 - $1.15 Million
-19,824 Reduced 7.06%
261,106 $13.4 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $662,898 - $741,223
-11,451 Reduced 3.92%
280,930 $16.3 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $358,496 - $398,053
5,627 Added 1.96%
292,381 $18.7 Million
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $3.59 Million - $4.07 Million
-54,604 Reduced 16.0%
286,754 $19.9 Million
Q4 2022

Jan 09, 2023

BUY
$68.48 - $81.09 $738,419 - $874,393
10,783 Added 3.26%
341,358 $0
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $1,064 - $629,319
8,190 Added 2.54%
330,575 $23.5 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $865,267 - $952,961
-11,915 Reduced 3.56%
322,385 $24.8 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $310,842 - $372,728
-5,056 Reduced 1.49%
334,300 $24.4 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $18.2 Million - $21.2 Million
339,356 New
339,356 $21.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.